These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3731351)

  • 1. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.
    Fukuda N; Higuchi N; Ohno M; Kenmochi H; Sekikawa H; Takada M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1366-9. PubMed ID: 3731351
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of cyclodextrins on sparingly soluble salts.
    Hirsch W; Fried V; Altman L
    J Pharm Sci; 1985 Oct; 74(10):1123-5. PubMed ID: 4078713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
    Aboutaleb AE; Abdel Rahman A; Samy EM
    J Pharm Belg; 1988; 43(6):437-44. PubMed ID: 3150006
    [No Abstract]   [Full Text] [Related]  

  • 10. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract]   [Full Text] [Related]  

  • 11. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of freezing point depression to drug interaction studies. I. Interaction between cyclodextrins and alcohols.
    Suzuki M; Ueda S; Kusai A
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):720-5. PubMed ID: 3409380
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct liquid chromatographic separation of racemates with an alpha-cyclodextrin bonded phase.
    Armstrong DW; Yang XF; Han SM; Menges RA
    Anal Chem; 1987 Nov; 59(21):2594-6. PubMed ID: 3688447
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.